Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2002
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with generally accepted scientific standards and described in sufficient detail

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2002

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-ketogluconic acid, calcium salt
EC Number:
919-553-2
Cas Number:
28098-92-2
Molecular formula:
C6H10O7.xCa
IUPAC Name:
2-ketogluconic acid, calcium salt
Test material form:
solid

Test animals

Species:
rat
Strain:
Wistar
Sex:
female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
The animals of the treated group, received an effective dose of 2000 mg/kg body weight of the test
item Acide 2-cetogluconique, sel de calcium, diluted in distilled water and administered by gavage
under a volume of 10 mL/kg body weight using a suitable syringe graduated fitted with an
oesophageal metal canula.
Doses:
2000mg/kg
No. of animals per sex per dose:
6
Control animals:
yes

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality occurred during the study.
Clinical signs:
other: No clinical signs related to the administration of the test item were observed.
Gross pathology:
The macroscopical examination of the animals at the end of the study did not reveal treatment-related
changes.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The test item Acide 2-cetogluconique, sel de calcium was administered by oral route to a group of 6
female Sprague Dawley rats at the single dose of 2000 mg/kg body weight. The experimental protocol
was established on the basis of the official method as defined in the O.E.C.D. guideline N° 423 dated
December 17th, 2001 and the test method B.1ter of the Council regulation No 440/2008.
No mortality occurred during the study.
No clinical signs related to the administration of the test item were observed.
The body weight evolution of the animals remained normal throughout the study.
The macroscopical examination of the animals at the end of the study did not reveal treatment-related
changes.
In conclusion, the LD50 of the test item Acide 2-cetogluconique, sel de calcium is higher than 2000
mg/kg body weight by oral route in the rat.
In accordance with the OECD guideline n°423, the LD50 of the test item may be considered higher
than 5000 mg/kg body weight by oral route in the rat.
According to the criteria for classification, packaging and labelling of dangerous substances and
preparations in accordance with the E.E.C. Directives 67/548, 2001/59 and 99/45, the test item Acide
2-cetogluconique, sel de calcium must not be classified. No symbol and risk phrase are required.
In accordance with the Globally Harmonized System (Regulation (EC) No 1272/2008), the test item
must not be classified in category 4. No signal word and hazard statement are required.